DrugPatentWatch Database Preview
PROLIA Drug Profile
» See Plans and Pricing
Summary for Tradename: PROLIA
| Patents: | 107 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for PROLIA |
| Recent Clinical Trials: | See clinical trials for PROLIA |
Recent Clinical Trials for PROLIA
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Columbia University | Phase 2 |
| Kunming Pharmaceuticals, Inc. | Phase 1 |
| Australian and New Zealand Intensive Care Research Centre | Phase 2 |
Pharmacology for PROLIA
| Mechanism of Action | RANK Ligand Blocking Activity |
Company Disclosures: US Patents for PROLIA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | Get Started for $10 | Immunex Corporation (Seattle, WA) | 2016-12-23 | RX | Orphan | company |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | Get Started for $10 | Amgen Inc. (Thousand Oaks, CA) | 2017-04-16 | RX | Orphan | company |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | Get Started for $10 | Amgen Inc. (Thousand Oaks, CA) Amgen Fremont Inc. (Fremont, CA) | 2021-06-26 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for PROLIA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | Get Started for $10 | Fundacio Institut de Recerca Biomedica (IRB Barcelona) (Barcelona, ES) Institucio Catalana de Recerca I Estudis Avancats (Barcelona, ES) | 2039-02-26 | RX | Orphan | search |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | Get Started for $10 | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | Orphan | search |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | Get Started for $10 | Fundacio Institut de Recerca Biomedica (IRB Barcelona) (Barcelona, ES) Institucio Catalana de Recerca I Estudis Avancats (Barcelona, ES) | 2030-10-06 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for PROLIA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2952083 | Get Started for $10 |
| Spain | 2608495 | Get Started for $10 |
| Japan | 2018102316 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for PROLIA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 132010901893988 | Italy | Get Started for $10 | PRODUCT NAME: DENOSUMAB(PROLIA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/10/618/001-004, 20100526 |
| 300465 | Netherlands | Get Started for $10 | PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE: EU/1/10/618/001-004 20100526 |
| 91757 | Luxembourg | Get Started for $10 | PRODUCT NAME: DENOSUMAB ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (PROLIA ); AUTHORISATION NUMBER AND DATE: EU/1/10/618/001-004 20100528 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
